A recent retrospective study identified that long-term GnRH agonist pre-treatment significantly improved the implantation rate, clinical pregnancy rate, and on-going pregnancy rate of patients with adenomyosis in FET cycles (8). The gene discussed is GNRH1; the disease is adenomyosis.